Drugs / PF-04427429
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01511497 | Oct 2011 → Jan 2013 | migraine disorder | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01147432 | Aug 2010 → Oct 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01165723 | Aug 2010 → Jan 2012 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01117233 | May 2010 → Nov 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01011296 | Dec 2009 → May 2010 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04427429 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01011296 ↗ |
| Route | Intravenous | “administered intravenously” NCT01011296 ↗ |